Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
31 - 40 out of 272Page size: 10
  1. 2022
  2. Published

    COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

    Holmstroem, R. B., Nielsen, Ole Haagen, Jacobsen, Søren, Riis, Lene Buhl, Theile, S., Bjerrum, Jakob Tveiten , Vilmann, Peter, Johansen, Julia Sidenius, Boisen, M. K., Eefsen, R. H. L., Svane, Inge Marie, Nielsen, Dorte Lisbet & Chen, I. M., 2022, In: Journal for ImmunoTherapy of Cancer. 10, 9

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

    Pedersen, S., Larsen, K. O., Christensen, Alex Hørby, Svane, Inge Marie, Zerahn, B. & Ellebaek, E., 2022, In: Acta Oncologica. 61, 1, p. 45-51

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Clinical advances and ongoing trials on mRNA vaccines for cancer treatment

    Lorentzen, C. L., Haanen, J. B., Met, Özcan & Svane, Inge Marie, 2022, In: The Lancet Oncology. 23, 10, p. e450-e458

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

    Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Coexisting Alterations of MHC Class I Antigen Presentation and IFNg Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy

    Nielsen, M., Presti, M., Sztupinszki, Z., Jensen, Agnete Witness Præst, Draghi, A., Chamberlain, C. A., Schina, A., Yde, C. W., Wojcik, J., Szallasi, Z., Crowther, M. D., Svane, Inge Marie & Donia, M., 2022, In: Cancer Immunology Research. 10, 10, p. 1254-1262 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial

    Holmberg-Thydén, S., Dufva, I. H., Gang, Anne Ortved, Breinholt, M. F., Schejbel, L., Andersen, M. K., Kadivar, M., Svane, Inge Marie, Grønbæk, Kirsten, Hadrup, S. R. & El Fassi, D., 2022, In: Cancer Immunology, Immunotherapy. 71, p. 433-444

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

    Omland, S. H., Ejlertsen, J. S., Krustrup, D., Christensen, R. L., Svane, Inge Marie, Olesen, U. H. & Hædersdal, Merete, 2022, In: Cancers. 14, 23, 5815.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

    Willumsen, N., Jensen, C., Green, G., Nissen, N. I., Neely, J., Nelson, D. M., Pedersen, R. S., Frederiksen, P., Chen, I. M., Boisen, M. K., Johansen, A. Z., Madsen, D. H., Svane, I. M., Lipton, A., Leitzel, K., Ali, S. M., Erler, J. T., Hurkmans, D. P., Mathijssen, R. H. J., Aerts, J. & 5 others, Eslam, M., George, J., Christiansen, C., Bissel, M. J. & Karsdal, M. A., 2022, In: Cellular and Molecular Life Sciences. 79, 4, 11 p., 204.

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

    Chamberlain, C. A., Bennett, Eric Paul, Kverneland, Anders Handrup, Svane, Inge Marie, dqp123, dqp123 & Met, Özcan, 2022, In: Molecular Therapy - Oncolytics. 24, p. 417-428 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges

    Saini, K. S., Svane, Inge Marie, Juan, M., Barlesi, F. & André, F., 2022, In: Annals of Oncology. 33, 1, p. 6-12 7 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 4054758